Venky Raghavan

Company: Novartis AG

Job title: Executive Director - Search & Evaluation Oncology

Bio:

Venky Raghavan leads Oncology Search and Evaluation at Novartis focused on solid tumors and is looking for partnership and M&A opportunities that can help bring transformative therapies to patients with debilitating cancers.

Venky came to Novartis from Bayer where he was an S&E lead for solid tumors, and prior to that held roles in global marketing. Prior to his career in pharma, he spent years in strategy consulting at IQVIA and Oliver Wyman.

~ “This is a good opportunity to network with peers and identify ways to accelerate paradigm-shifting ADCs & Radioligand therapies from bench-side to bed-side”

Seminars:

Pharma Icebreaker: Activity in ADCs, Appetite for Radioligands & Alignment for Business 8:00 am

Discussing recent deal-making and current search and evaluation interests for context in the conference to follow Sharing insights into decision-making, due diligence, and necessary data packages to more confidently bring information to networking conversations Collectively hypothesizing future radioligand and ADC trends to present the buyer’s perspective on the potential of innovation in earlier developmentRead more

day: Day One - AM

Search & Evaluation Roundtables for Pharma Partnerships 10:15 am

Immerse yourself in the most valuable networking of the conference, and qualify yourself as a valuable prospect through face-to-face meetings with the pharma faculty. Rotate through pharma tables to understand how you align with search and evaluation interests, hear in-person feedback, and introduce your ADC innovations to multiple stakeholders. Select your tables ahead of time,…Read more

day: Day One - AM